Scarica l'app Stockscreener
5.74
2.05%
-0.12
Dopo l'orario di chiusura:
5.71
-0.03
-0.52%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.86
Aprire:
$5.72
Volume 24 ore:
3.89M
Relative Volume:
4.40
Capitalizzazione di mercato:
$444.17M
Reddito:
$83.57M
Utile/perdita netta:
$-4.94M
Rapporto P/E:
-63.78
EPS:
-0.09
Flusso di cassa netto:
$6.97M
1 W Prestazione:
+56.40%
1M Prestazione:
+69.82%
6M Prestazione:
+51.85%
1 anno Prestazione:
+287.84%
Intervallo 1D:
$5.36
$6.18
Intervallo di 1 settimana:
$3.49
$6.18
Portata 52W:
$1.32
$6.18
Chromadex Corp Stock (CDXC) Company Profile
Nome
Chromadex Corp
Settore
Industria
Telefono
310-388-6706
Indirizzo
10900 WILSHIRE BLVD, LOS ANGELES
Chromadex Corp Stock (CDXC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-08-16 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-08-11 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | Iniziato | ROTH Capital | Buy |
| 2019-10-16 | Iniziato | Oppenheimer | Outperform |
| 2019-02-14 | Iniziato | B. Riley FBR | Buy |
| 2017-11-27 | Ripresa | H.C. Wainwright | Buy |
| 2017-09-25 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-01-03 | Iniziato | Rodman & Renshaw | Buy |
Mostra tutto
Chromadex Corp Borsa (CDXC) Ultime notizie
ChromaDex records 31% sales growth; stock PT raised to $8 by H.C. Wainwright - Investing.com
Are Investors Keen On Selling Holdings In Chromadex Corp (NASDAQ: CDXC)? - Stocks Register
ChromaDex (NASDAQ:CDXC) Given New $8.00 Price Target at HC Wainwright - MarketBeat
BSW Wealth Partners Acquires Shares of 88,847 ChromaDex Co. (NASDAQ:CDXC) - MarketBeat
Equities Analysts Issue Forecasts for ChromaDex Q2 Earnings - MarketBeat
ChromaDex (NASDAQ:CDXC) Issues Quarterly Earnings Results - MarketBeat
ChromaDex Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
ChromaDex stock soars to 52-week high, hits $4.69 By Investing.com - Investing.com Nigeria
ChromaDex stock soars to 52-week high, hits $4.69 - Investing.com India
ChromaDex (CDXC) Beats Q3 Earnings and Revenue Estimates - MSN
ChromaDex Corp (CDXC) Q3 2024 Earnings: EPS of $0.02 Beats Estimates, Revenue Hits $25.6 Million - GuruFocus.com
ChromaDex Corp (CDXC) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
ChromaDex surges on surprise Q3 profit - XM
ChromaDex: Q3 Earnings Snapshot - New Haven Register
ChromaDex Reports Strong Q3 2024 Financial Results - TipRanks
ChromaDex Corporation Reports Third Quarter 2024 Financial Results - BioSpace
ChromaDex Shares Climb on Forecast for 15% Revenue Growth - MarketWatch
Chromadex Reports Strong Q3 2024 with 31% Sales Increase - TipRanks
ChromaDex reports Q3 EPS 2c, consensus 0c - TipRanks
ChromaDex sees FY24 revenue growth 15% - TipRanks
ChromaDex Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
ChromaDex Gears Up to Report Q3 Earnings: Here's What to Expect - MSN
Curious About NAD+? Here’s How It Works and How to Try It At Home - NewBeauty Magazine
ChromaDex Q3 2024 Earnings Preview - MSN
ChromaDex Corp (CDXC) Q3 2024 Earnings Report Preview: What To E - GuruFocus.com
Insights into ChromaDex's Upcoming Earnings - Benzinga
ChromaDex Co. (NASDAQ:CDXC) Sees Significant Drop in Short Interest - MarketBeat
$9M Fee Awarded For 'Feeble' Milk Vitamin Eligibility Row - Law360
ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024 - The Bakersfield Californian
ChromaDex (CDXC) Stock Price, News & Analysis - MarketBeat
ChromaDex (CDXC) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
ChromaDex Leads The Charge With 2 Other US Penny Stocks To Watch - Yahoo Finance
ChromaDex to Participate in the 17th Annual LD Micro Main Event - The Bakersfield Californian
Are Medical Stocks Lagging ChromaDex (CDXC) This Year? - Yahoo Finance
Recent Insider Activity Could Benefit Chromadex Corp (CDXC) - Knox Daily
Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN) - StreetInsider.com
Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN) – Company AnnouncementFT.com - Financial Times
ChromaDex parts with accountant over independence concerns By Investing.com - Investing.com South Africa
ChromaDex parts with accountant over independence concerns - Investing.com India
Marshall Wace LLP Acquires New Stake in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex Corp (CDXC) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Challenges - Yahoo Finance
Rhumbline Advisers Purchases Shares of 45,519 ChromaDex Co. (NASDAQ:CDXC) - Defense World
Is ChromaDex (CDXC) Stock Outpacing Its Medical Peers This Year? - MSN
ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference - The Bakersfield Californian
Two Polish men extradited to NI jailed for drugs offences - Ireland Live
A new experience centre in Bengaluru decodes whisky, gin, and heritage brews of India - Condé Nast Traveller India
Nu Republic launches Cyberstud X2 and Cyberstud X4 Firefly TWS in India - Techlomedia
XLRI JAMSHEDPUR’S PRODZION CLUB HOSTS ITS SECOND PRODUCT SYMPOSIUM: AURORA 2.0 - India Education Diary
Jharkhand News: XLRI Jamshedpur hosts product symposium Aurora - The Jharkhand Story
NI Courts Service awards £85M contract to Canadian IT firm CGI - Belfast Live
Nu Republic Unveils Cyberstud X2 and X4 Firefly Wireless Earbuds - Gadget Bridge
Chromadex Corp Azioni (CDXC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):